¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : Ä¡·á¹ýº°, µ¿¹°º°, ¾Ï À¯Çüº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal (Canine, Feline), By Cancer Type (Skin Cancer, Lymphoma, Sarcomas), And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1552573
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå ±Ô¸ð´Â 2024-2030³â°£ 10.76%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³»°í, 2030³â±îÁö 10¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ý·Áµ¿¹°ÀÇ ¾Ï À¯º´·ü Áõ°¡, ¹Ý·Áµ¿¹° ¼ÒÀ¯ÁÖµéÀÇ ¹Ý·Áµ¿¹°À» À§ÇÑ ÁöÃâ ÀÇÇâ, ¿¬±¸ÀÚµéÀÌ ÀÓ»ó½ÃÇè ¸ðµ¨·Î °³¸¦ »ç¿ëÇÏ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, °í¾çÀÌÀÇ ¾Ï ¹ßº´·ü Áõ°¡¿Í ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇÑ ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ±â¾÷µéÀº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ ÀμöÇÕº´, ¿¬±¸ °è¾à, Á¦ÈÞ, ÆÄÆ®³Ê½Ê, Áö¸®Àû È®Àå, Á¦Ç° °³¹ß µîÀÇ Àü·«À» äÅÃÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2020³â 11¿ù ¹ö¹Ú(Virbac)Àº °³ ºñ¸¸¼¼Æ÷Á¾¿¡ ´ëÇÑ »õ·Î¿î Á¾¾ç ³» ÁÖ»ç Ä¡·áÁ¦ÀÎ ½ºÅÚÆùŸ(Stelfonta)ÀÇ ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ Elanco´Â ¹Ý·Áµ¿¹° ÀǾàǰ ÆÄÀÌÇÁ¶óÀÎÀ» À§ÇØ Aratana Therapeutics¸¦ ÀμöÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ¶ÇÇÑ VetDC·ÎºÎÅÍ ¶ó¹ÙÄíÆ÷»çµò(Tanovea)À» °³¹ßÇϱâ À§ÇÑ °è¾àÀ» ü°áÇß½À´Ï´Ù. ¶ÇÇÑ 2021³â 7¿ù ¿¤¶ûÄÚ´Â FDA°¡ °³ ¸²ÇÁÁ¾ Ä¡·áÁ¦·Î¼­ Ÿ³ëº£¾Æ¿¡ ´ëÇÑ ¿ÏÀüÇÑ ½ÂÀÎÀ» ¹Þ¾Ò´Ù°í ¼±¾ðÇß½À´Ï´Ù. µû¶ó¼­ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È Ä¡¿­ÇÑ °æÀïÀ» È®ÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ ¾Ï À¯º´·ü Áõ°¡´Â È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀÇ Çʿ伺À» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°³¿¡¼­ ¸ÍÀå°ñÀ°Á¾Àº ¸Å¿ì °ø°ÝÀûÀÎ ÁúȯÀ¸·Î, ¿ÏÄ¡¸¦ À§ÇÑ Ä¡·á´Â Á¾¾çÀÇ ¿Ü°úÀû ÀýÁ¦¼ú°ú Á¾¾ç ¼¼Æ÷°¡ ´Ù¸¥ ºÎÀ§, ƯÈ÷ Æó·Î ÀüÀÌµÉ À§ÇèÀ» ÁÙÀ̱â À§ÇÑ È­Çпä¹ýÀ¸·Î ÀÌ·ç¾îÁý´Ï´Ù. °ñµç ¸®Æ®¸®¹ö¶ó´Â °ßÁ¾Àº ´Ù¸¥ °ßÁ¾¿¡ ºñÇØ ¾Ï ¹ßº´·üÀÌ ³ôÀº °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. °ñµç ¸®Æ®¸®¹ö´Â ¹Ì±¹¿¡¼­ °¡Àå Àαâ ÀÖ´Â °ßÁ¾ Áß ÇϳªÀ̸ç, ¹Ý·Áµ¿¹°ÀÇ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀº ¼öÀÇ Á¾¾çÇп¡¼­ Áß¿äÇÑ ºÎºÐÀÔ´Ï´Ù. ¹Ý·Áµ¿¹° ¼ö¼úÀ» Æ÷ÇÔÇÑ ÀÓ»ó ¿¬±¸ÀÇ °¡¼ÓÈ­´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2019³â 5¿ù ¿À¸®°Ç ÁÖ¸³´ëÇÐÀº Á¾¾çÀ» ¿ÏÀüÈ÷ Á¦°ÅÇÑ °³¿¡¼­ ¾Ï Àç¹ß À§ÇèÀÌ 60%±îÁö °¨¼ÒÇß´Ù´Â ¿¬±¸ °á°ú¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â ¹Ý·Áµ¿¹°À» Ű¿ì´Â Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼­´Â Àü±¹ ¹Ý·Áµ¿¹° ÁÖ°£ µî ¹Ý·Áµ¿¹° °Ç°­¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ ´Ù¾çÇÑ Çà»ç°¡ ¿­¸®°í ÀÖ½À´Ï´Ù. µ¿¹°ÀÌ °³Àο¡°Ô Äڷγª19¸¦ Àü¿°½Ãų À§ÇèÀº °ÅÀÇ ¾ø´Â °ÍÀ¸·Î ¿©°ÜÁöÁö¸¸, FDA´Â Äڷγª19ÀÇ ´ëÀ¯ÇàÀÌ µ¿¹°¿ë ½Å¾à °³¹ßÀ» À§ÇÑ ÁøÇà ÁßÀÎ ¿¬±¸¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ´Ù°í °æ°íÇß½À´Ï´Ù. ÀÌ¿¡ µû¶ó 2020³â 4¿ù, Äڷγª19°¡ µ¿¹° ½Å¾à °³¹ß¿¡ ¹ÌÄ¥ ¼ö ÀÖ´Â ÀáÀçÀû ¿µÇâÀ» ÁÙÀ̱â À§ÇÑ °¡À̵å¶óÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå : µ¿¹°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå : Ä¡·á¹ý, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ ¼öÀÇ Á¾¾çÇÐ ½ÃÀå : ¾Ï À¯Çü, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

Á¦8Àå ÁÖ¿ä Æ÷ÀÎÆ®

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Veterinary Oncology Market Growth & Trends:

The U.S. veterinary oncology market size is expected to reach USD 1.08 billion by 2030, registering a CAGR of 10.76% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cancer in pets, willingness to spend on them by pet owners, and use of canines as a model for clinical trials by researchers are the key contributing factor toward the market growth. In addition, a rise in the incidence of cancer in the feline population and rising pet ownership resulting in the increased focus on pet health is further expected to spur the growth. Moreover, companies are increasingly adopting strategies, such as M&As, research agreements, collaboration, partnerships, geographic expansion, and product development to enhance their market position.

For instance, in November 2020, Virbac publicized the approval of Stelfonta, a novel intratumoral injection treatment for canine mast cell tumors. In addition, Elanco purchased Aratana Therapeutics for its pet products pipeline. The company also had an agreement to create rabacfosadine (Tanovea), a drug from VetDC. In addition, in July 2021, Elanco proclaimed that the FDA granted full approval of Tanovea for the lymphoma treatment in dogs. Hence, the market is expected to witness intense competition over the forecast period. The growing prevalence of cancer in companion animals is expected to propel the need for effective treatment options.

In canines, appendicular osteosarcoma is an extremely aggressive illness and curative-intent treatment comprises surgical resection of the tumor followed by chemotherapy to diminish the risk of tumor cells spreading to other areas, particularly the lungs. The golden retriever breed has been reported to have a high cancer prevalence compared to others. Golden Retriever is one of the favorite breeds in the U.S. and increasing concerns regarding the wellbeing of pets are contributing to the market growth. Clinical trials are a critical aspect of veterinary oncology. The accelerated number of clinical research involving surgical procedures in pets is further fueling the market growth.

For instance, in May 2019, Oregon State University conducted a research study stating that the risk of cancer recurrence reduced to 60% in dogs whose tumors were completely resected. With the growing number of pet parents in the U.S., animal health awareness is rising among people. In the U.S., various pet health awareness events are conducted to spread awareness, such as National Pet Week. The risk of animals spreading COVID-19 to individuals is considered to be little. The FDA is alert that the COVID-19 pandemic may influence the ongoing studies being conducted to provision new animal drug development. Thereby, guidelines were issued in April 2020 to help diminish the potential impact of the pandemic on new animal drug development.

U.S. Veterinary Oncology Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Veterinary Oncology Market Variables, Trends, & Scope

Chapter 4. U.S. Veterinary Oncology Market: Animal Estimates & Trend Analysis

Chapter 5. U.S. Veterinary Oncology Market: Therapy Estimates & Trend Analysis

Chapter 6. U.S. Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

Chapter 7. Competitive Landscape

Chapter 8. Key Takeaways

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â